XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
EMPLOYEE STOCK COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense
The following table presents total stock-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended
September 30,
Nine Months Ended
September 30,
($ in thousands)2022202120222021
Restricted stock awards and units$1,715 $1,106 $4,482 $3,988 
Related tax benefits$495 $326 $1,295 $1,175 
Schedule of Restricted Stock and Restricted Stock Units Activity
The following table presents unvested restricted stock awards and restricted stock units activity for the three and nine months ended September 30, 2022:
Three Months Ended
September 30, 2022
Nine Months Ended
September 30, 2022
Number of SharesWeighted Average Grant Date Fair Value Per ShareNumber of SharesWeighted
Average Grant
Date Fair Value
Per Share
Outstanding at beginning of period1,403,060 $14.77 649,010 $17.17 
Granted (1)
29,935 $13.88 1,051,117 $13.66 
Vested (2)
(29,983)$15.20 (269,302)$16.21 
Forfeited (3)
(10,919)$18.83 (38,732)$17.72 
Outstanding at end of period1,392,093 $14.71 1,392,093 $14.71 
(1)There were 17,759 and 782,451 performance-based shares/units included in shares granted for the three and nine months ended September 30, 2022.
(2)There were 17,657 and 42,440 performance-based shares/units included in vested shares for the three and nine months ended September 30, 2022.
(3)The number of forfeited shares included aggregate performance-based shares/units of zero and 9,428 for the three and nine months ended September 30, 2022.
Schedule of Option Activity The following tables represents stock option activity for the three and nine months ended September 30, 2022:
Three Months Ended September 30, 2022
Nine Months Ended
September 30, 2022
($ in thousands, except per share data)Number
of Shares
Weighted-Average Exercise Price Per ShareNumber
of Shares
Weighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregate Intrinsic Value
Outstanding at beginning of period14,904 $13.05 14,904 $13.05 
Exercised— $— — $— 
Outstanding at end of period14,904 $13.05 14,904 $13.05 2.5 years$44 
Exercisable at end of period14,904 $13.05 14,904 $13.05 2.5 years$44